实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (2): 265-268.doi: 10.3969/j.issn.1672-5069.2026.02.026

• 肝硬化 • 上一篇    下一篇

内镜下硬化剂治疗肝硬化并发食管静脉曲张破裂出血患者心肌损伤临床研究*

周慧敏, 王娜, 刘晶晶, 郭亚荣, 柴宝   

  1. 030032 太原市 山西医科大学第三医院消化内科(周慧敏,王娜,刘晶晶,柴宝);消化系统肿瘤科(郭亚荣)
  • 收稿日期:2025-04-21 出版日期:2026-03-10 发布日期:2026-03-13
  • 通讯作者: 柴宝,E-mail:chaibaocb@126.com
  • 作者简介:周慧敏,女,26岁,硕士研究生。E-mail:zhouhuimin0721@163.com
  • 基金资助:
    *山西省基础研究计划项目(编号:202303021221220)

Prevalence and risk factors of myocardial injury in patients with liver cirrhosis complicated with esophageal variceal bleeding after endoscopic sclerotherapy

Zhou Huimin, Wang Na, Liu Jingjing, et al   

  1. Department of Gastroenterology, Third Hospital, Affiliated to Shanxi Medical University, Taiyuan 030032, Shanxi Province, China
  • Received:2025-04-21 Online:2026-03-10 Published:2026-03-13

摘要: 目的 探讨肝硬化并发食管静脉曲张破裂出血(EVB)患者接受胃镜下硬化剂治疗对心肌损伤的影响,并分析相关危险因素。方法 2023年1月~2024年6月我院消化内科收治的98例EVB患者,其中66例接受胃镜下曲张静脉硬化治疗,另32例接受内科药物治疗。采用化学发光法检测心肌酶谱和B型钠尿肽(BNP)水平。采用多因素Logistic回归分析影响心肌损伤发生的危险因素。结果 在入院12 h内,硬化治疗患者心肌损伤发生率为42.4%,显著高于内科治疗组的28.1%(P<0.05);硬化治疗组肌钙蛋白(CTnI)、肌红蛋白(MYO)和肌酸激酶同工酶(CK-MB)水平分别为(0.028±0.018)μg/L、(55.1±4.4)μg/L和(35.2±18.6)U/L,均显著高于对照组【分别为(0.008±0.003)μg/L、(48.3±4.5)μg/L和(17.9±11.5)U/L,P<0.05】;单因素分析显示,硬化治疗患者发生心肌损伤组有心脏疾病史和糖尿病史、肝功能B/C级占比分别为65.0%、69.2%、89.2%,显著高于无心肌损伤组的35.0%、20.8%、76.3%(P<0.05),心肌损伤组年龄、休克指数、BNP、手术操作时间、肌酐(Cr)水平分别为(66.4±12.3)岁、(1.2±0.6)、(178.6±22.8)pg/ml、(18.9±3.5)min和(97.9±8.6)μmol/L,均显著高于无心肌损伤组【分别为(57.4±9.2)岁、(0.7±0.4)、(119.4±15.7)pg/ml、(15.4±3.8)min和(77.2±8.9)μmol/L,P<0.05】,血清白蛋白(ALB)水平为(25.8±3.2)g/L,显著低于无心肌损伤组【(33.4±4.3)g/L,P<0.05】;多因素Logistic回归分析显示年龄、肝功能分级、术前休克指数、手术操作时间、心脏疾病史、糖尿病史、血清BNP、ALB和Cr水平是硬化剂治疗患者发生急性心肌损伤的独立危险因素(P<0.05)。结论 肝硬化并发EVB接受硬化治疗患者并发急性心肌损伤发生率较高,且危险因素多样。临床应重视术前评估和术中监测,针对高危患者采取个体化的防治措施,以降低发生心肌损伤的风险。

关键词: 食管静脉曲张破裂出血, 硬化治疗, 急性心肌损伤, 危险因素

Abstract: Objective This study aimed to investigate prevalence and risk factors of myocardial injury (MCI) in patients with liver cirrhosis complicated with esophageal variceal bleeding (EVB) after endoscopic sclerotherapy. Methods Ninety-eight patients with decompensated liver cirrhosis and EVB were urgently admitted to our hospital between January 2023 and June 2024, 66 patients received urgent gastroscopic varicose vein sclerotherapy and another 32 patients were treated conventionally with internal medicine. Serum troponin (CTnI), myoglobin(MYO) and creatine kinase isoenzyme (CK-MB), and B-type natriuretic peptide (BNP) levels were detected routinely. Multivariate Logistic regression analysis was applied to find risk factors for MCI. Results Within 12 hours after admission, the incidence of MCI in the sclerotherapy group was 42.4%, much higher than 28.1%(P<0.05) in internal medicine-treated group; serum CTnI, MYO and CK-MB levels in sclerotherapy group were (0.028±0.018)μg/L, (55.1±4.4)μg/L and (35.2±18.6)U/L, all significantly higher than [(0.008±0.003)μg/L, (48.3±4.5)μg/L and (17.9±11.5)U/L, respectively, P<0.05] in the control; percentages of cardiac disease history, diabetes, Child class B/C in patients with MCI were 65.0%, 69.2% and 89.2%, all significantly higher than 35.0%, 20.8% and 76.3%(P<0.05), the age, shock index, serum BNP level, operation time and serum creatinine (sCr) level were(66.4±12.3)yr, (1.2±0.6), (178.6±22.8)pg/ml, (18.9±3.5)min and (97.9±8.6)μmol/L, all much greater or higher than [(57.4±9.2)yr, (0.7±0.4), (119.4±15.7)pg/ml, (15.4±3.8)min and (77.2±8.9)μmol/L, respectively, P<0.05], while serum albumin level was (25.8±3.2)g/L, much lower than [(33.4±4.3)g/L, P<0.05] in those without MCI; multivariate Logistic analysis showed that age, Child class, shock index, operation time, cardiac disease, diabetes, serum BNP, albumin and sCr levels were all the independent risk factors for occurrence of MCI (P<0.05). Conclusion The incidence of acute myocardial injury in patients with cirrhosis complicated with EVB undergoing sclerotherapy is high, and the risk factors are diverse. Clinicians should pay more attention to preoperative assessment and intraoperative monitoring, and take measures to prevent and manage it.

Key words: Esophageal variceal bleeding, Endoscopic sclerotherapy, Acute myocardial damage, Risk factor